Related Experiment Video
Updated: Apr 13, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Blood lead levels and childhood asthma
Ahmed Abdullah Mohammed1, Faisal Yosef Mohamed, El-Sayed El-Okda
1Departments of Pediatrics and *Community medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Correspondence to: Dr Ahmed Abdullah Mohammed, Assistant Professor of Pediatrics, Ain Shams University, Faculty of Medicine, Abbassia, Cairo Egypt. PO Box 11566. ahmedazrak@gmail.com.
Insights
Elevated blood lead levels in children are not linked to asthma diagnosis but may worsen asthma severity. Higher lead levels correlated with increased eosinophilia and immunoglobulin E, indicating a potential link to more severe allergic responses in asthmatic children.
Area of Science:
- Environmental Health
- Pediatric Allergy
- Toxicology
Background:
- Bronchial asthma is a common chronic respiratory disease in children.
- Environmental factors, including lead exposure, are increasingly investigated for their role in asthma pathogenesis.
- Understanding the relationship between blood lead levels and asthma severity is crucial for public health initiatives.
Purpose of the Study:
- To measure blood lead levels in children aged 5-14 years diagnosed with bronchial asthma.
- To investigate the correlation between blood lead levels and the severity of asthma in affected children.
- To compare blood lead levels in asthmatic children with those in healthy controls.
Main Methods:
- A cross-sectional analytical study was conducted at a Pediatric Allergy and Immunology Clinic in Cairo, Egypt.
- Blood lead levels were measured using the atomic absorption spectrophotometer technique.
- 200 children with bronchial asthma and 125 healthy controls were enrolled.
Main Results:
- No significant difference in mean blood lead levels was found between asthmatic children and controls.
- A high prevalence of elevated blood lead levels (>10 ug/dL) was observed in both groups (58.5% overall).
- Elevated blood lead levels were associated with higher frequencies of eosinophilia, increased total immunoglobulin E, and greater asthma severity.
Conclusions:
- Blood lead levels are not significantly associated with the diagnosis of asthma.
- Elevated blood lead levels appear to be linked to increased asthma severity.
- Higher blood lead levels correlate with increased eosinophilia and immunoglobulin E levels in asthmatic children.
Objective:
To measure blood lead levels in children (5-14 y) with bronchial asthma, and correlate with asthma severity.
Design:
Cross-sectional analytical.
Setting:
Pediatric Allergy and Immunology Clinic of a Childrens hospital in Cairo, Egypt.
Participants:
200 children (127 males) with bronchial asthma and 125 age- and sex-matched healthy controls (80 males).
Procedure:
Blood lead levels were measured by atomic absorption spectrophotometer technique, and were subsequently correlated with asthma severity.
Results:
No significant difference in mean (SD) blood lead levels was observed between children with asthma [13.3 (4.8) ug/dL] and control group [11.4 (3.9) ug/dL]. 190 children (58.5%) had elevated blood lead levels (>10 ug/dL), with no significant difference between patients (60%) and controls (56%). Patients with elevated blood lead levels had significantly higher frequency of eosinophilia (66.7%) and increased total immunoglobulin E (83.3%) compared to other patients with blood lead levels <10ug/dL (10% and 43.8%, respectively). Patients of asthma with elevated blood lead levels had higher grades of severity of asthma compared to those with blood lead levels <10 ug/dL.
Conclusions:
Blood lead levels are not significantly associated with diagnosis of asthma but elevated blood lead levels seem to be associated with increased asthma severity and higher frequency of eosinophilia and elevated immunoglobulin E levels.
Related Concept Videos
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:

